Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome
Author:
Affiliation:
1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston MA USA
2. Division of Cardiovascular Medicine; University of Pennsylvania; Philadelphia PA USA
Funder
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4668/fullpdf
Reference36 articles.
1. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization;Norhammar;J Am Coll Cardiol,2004
2. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes;Lettino;Eur Hear J - Cardiovasc Pharmacother,2017
3. Antithrombotic therapy for secondary prevention in patients with diabetes mellitus and coronary artery disease;Park;Circ J,2016
4. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction;Aguilar;Circulation,2004
5. Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: the OPTIMUS (optimizing antiplatelet therapy in diabetes mellitus)-4 study;Franchi;Circulation,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiplatelet Therapy for Secondary Prevention in Patients with Ischaemic Stroke and Transient Ischaemic Attack: A Retrospective Cohort Study in Malaysia;Medicine & Health;2023-12-28
2. The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies;American Journal of Epidemiology;2023-10-17
3. Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention;Clinical Pharmacology & Therapeutics;2022-12-28
4. Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes;Cardiovascular Therapeutics;2021-10-15
5. Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention;Journal of Cardiovascular Pharmacology;2021-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3